Skip to content

GENERAL ATLANTIC, L.P.

Follow

13F filer, CIK 1017645, New York, NY

GENERAL ATLANTIC, L.P. reported $2,906,996,055 across 12 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 98.97% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-26-002338

Period
2026-06-30
Reported value
$2.91B
Holdings
12
Top 10 weight
98.97%
New
3
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LFTOnew+25,315,646$608M
SPTXnew+6,101,582$133M
ALKTadded+4,041,543$73.2M
PBLSnew+1,538,461$42.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EWCZexited-13,110,492-$75.8M
RVMDreduced-350,000-$65.5M
CNTAexited-1,354,830-$53.8M
PHVSreduced-1,480,495-$51.2M
NRIXreduced-1,069,680-$26M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000950142-26-002338, largest first. % of portfolio is the value over $2,906,996,055, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LFTOLIFTOFF MOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 25,315,646 shares 25,315,646$608M20.92%newTimeline
DLODLOCAL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 63,906,695 shares; 2024Q4: 63,906,695 shares; 2025Q1: 63,906,695 shares; 2025Q2: 63,906,695 shares; 2025Q3: 46,656,695 shares; 2025Q4: 46,656,695 shares; 2026Q1: 46,656,695 shares; 2026Q2: 46,656,695 shares 46,656,695$606M20.86%0Timeline
CHYMCHIME FINL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 19,208,760 shares; 2025Q3: 19,208,760 shares; 2025Q4: 21,259,683 shares; 2026Q1: 21,259,683 shares; 2026Q2: 21,259,683 shares 21,259,683$435M14.98%0Timeline
ALKTALKAMI TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,520,318 shares; 2024Q4: 9,645,318 shares; 2025Q1: 9,645,318 shares; 2025Q2: 9,645,318 shares; 2025Q3: 11,991,480 shares; 2025Q4: 11,991,480 shares; 2026Q1: 15,337,495 shares; 2026Q2: 19,379,038 shares 19,379,038$351M12.08%+4,041,543Timeline
XPXP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 29,617,733 shares; 2024Q4: 29,617,733 shares; 2025Q1: 29,617,733 shares; 2025Q2: 25,517,733 shares; 2025Q3: 25,517,733 shares; 2025Q4: 22,699,133 shares; 2026Q1: 20,566,133 shares; 2026Q2: 20,566,133 shares 20,566,133$334M11.5%0Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,531,252 shares; 2024Q4: 7,531,252 shares; 2025Q1: 7,531,252 shares; 2025Q2: 7,531,252 shares; 2025Q3: 8,031,252 shares; 2025Q4: 8,031,252 shares; 2026Q1: 8,031,252 shares; 2026Q2: 6,550,757 shares 6,550,757$227M7.79%-1,480,495Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,101,582 shares 6,101,582$133M4.56%newTimeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,897,159 shares; 2026Q1: 4,101,865 shares; 2026Q2: 3,032,185 shares 3,032,185$73.6M2.53%-1,069,680Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,474,428 shares; 2025Q4: 2,812,928 shares; 2026Q1: 707,791 shares; 2026Q2: 357,791 shares 357,791$67M2.31%-350,000Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,538,461 shares 1,538,461$42.1M1.45%newTimeline
RSKDRISKIFIED LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,324,998 shares; 2024Q4: 5,324,998 shares; 2025Q1: 5,324,998 shares; 2025Q2: 5,324,998 shares; 2025Q3: 5,324,998 shares; 2025Q4: 5,324,998 shares; 2026Q1: 5,324,998 shares; 2026Q2: 5,324,998 shares 5,324,998$26.8M0.92%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 936,020 shares; 2024Q4: 2,474,859 shares; 2025Q1: 2,474,859 shares; 2025Q2: 2,474,859 shares; 2025Q3: 2,474,859 shares; 2025Q4: 2,474,859 shares; 2026Q1: 2,474,859 shares; 2026Q2: 2,474,859 shares 2,474,859$3.09M0.11%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
EWCZEUROPEAN WAX CTR INC13,110,492$75.8Mshares
CNTACENTESSA PHARMACEUTICALS PLC1,354,830$53.8Mshares
BULLWEBULL CORP50,816$244Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950142-26-002338 base2026-08-14acceptance time not in the bulk data set